- Spyre Therapeutics (NASDAQ:SYRE) announced on Monday that it has commenced an underwritten public offering of shares of its common stock or, in lieu of issuing common stock to certain investors, pre-funded warrants to purchase shares of its common stock.
- In
Spyre Therapeutics announces public offering of common stock and pre-funded warrants (SYRE:NASDAQ)
